Luis Garcia-Gancedo

Luis Garcia-Gancedo

Auto-generated profile, based on publicly available information

Luis Garcia-Gancedo


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MCMichelle Crouthamel
Michelle Crouthamel
EQEmilia Quattrocchi
Emilia Quattrocchi
SWSarah Watts
Sarah Watts
SWSherry Wang
Sherry Wang
PBPamela Berry
Pamela Berry
RWRachel E Williams
Rachel E Williams
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Using Smartphones to enroll, consent and gather patient-reported data has potential to enhance our understanding of disease burden and quantify physiological impact in the real-world. It may also be possible to harness integral Smartphone sensors to facilitate remote collection of clinically relevant data. Objective: The PAtient Rheumatoid Arthritis Data from the REal World (PARADE) observational study was conducted using a customized ResearchKit application (app) with a ‘bring your own device’ approach. The objective was to assess the feasibility of using an entirely digital approach (social media and Smartphone app) to conduct a real-world observational study of patients with rheumatoid arthritis (RA). Methods: The PARADE app, designed to guide patients through a series of tasks, was publicized via social media platforms and made available for patients in the USA to download from the iPhone App Store, as a means of patient recruitment. Patient-reported data, for example, medical history, RA-related medications (past and present), and a range of patient-reported outcome measures were collected. In addition, a joint pain map and a novel objective assessment of wrist range of motion (ROM), measured by the Smartphone embedded gyroscope and accelerometer, were included in the assessment. Results: Within 1 month of recruitment via social media campaigns, 399 participants self-enrolled, self-consented and provided complete demographic data. Joint pain was the most frequently reported RA symptom to bother study participants (344/393 [87.5%]). Severe patient-reported wrist pain appeared to be inversely linked with the range of wrist movement measured objectively by the app. At study entry, 292/399 participants (73%) indicated a preference for participating in a mobile app-based study. The number of participants in the study declined to 45/399 (11.3%) at week 12. Conclusions: Despite the declining number of participants over time, the combination of social media and Smartphone app with sensor integration was a feasible and cost-effective approach for the collection of patient-reported data in RA. Integral sensors within Smartphones can be harnessed to provide novel endpoints and the novel wrist ROM test warrants further clinical validation.

12 February 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
ACAndrew Creagh
Andrew Creagh
VHValentin Hamy
Valentin Hamy
HYHang Yuan
Hang Yuan
GMGert Mertes
Gert Mertes
RTRyan Tomlinson
Ryan Tomlinson
DCDavid A. Clifton
David A. Clifton
Digital measures of health status captured during daily life could greatly augment current in-clinic assessments for rheumatoid arthritis (RA), to enable better assessment of disease progression and impact. This work presents results from weaRAble-PRO, a 14-day observational study, which aimed to investigate how digital health technologies (DHT), such as smartphones and wearables, could augment patient reported outcomes (PRO) to determine RA status and severity in a study of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). Sensor-based measures of health status, mobility, dexterity, fatigue, and other RA specific symptoms were extracted from daily iPhone guided tests (GT), as well as actigraphy and heart rate sensor data, which was passively recorded from patients’ Apple smartwatch continuously over the study duration. We subsequently developed a machine learning (ML) framework to distinguish RA status and to estimate RA severity. It was found that daily wearable sensor-outcomes robustly distinguished RA from HC participants (F1, 0.807). Furthermore, by day 7 of the study (half-way), a sufficient volume of data had been collected to reliably capture the characteristics of RA participants. In addition, we observed that the detection of RA severity levels could be improved by augmenting standard patient reported outcomes with sensor-based features (F1, 0.833) in comparison to using PRO assessments alone (F1, 0.759), and that the combination of modalities could reliability measure continuous RA severity, as determined by the clinician-assessed RAPID-3 score at baseline (r2, 0.692; RMSE, 1.33). The ability to measure the impact of the disease during daily life—through objective and remote digital outcomes—paves the way forward to enable the development of more patient-centric and personalised measurements for use in RA clinical trials.

20 December 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LGLuis Garcia-Gancedo
Luis Garcia-Gancedo
MKMadeline L Kelly
Madeline L Kelly
ALArseniy Lavrov
Arseniy Lavrov
JPJim Parr
Jim Parr
RHRob Hart
Rob Hart
AAAmmar Al-Chalabi
Ammar Al-Chalabi
Background: Objective symptom monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) has the potential to provide an important source of information to evaluate the impact of the disease on aspects of real-world functional capacity and activities of daily living in the home setting, providing useful objective outcome measures for clinical trials. Objective: This study aimed to investigate the feasibility of a novel digital platform for remote data collection of multiple symptoms—physical activity, heart rate variability (HRV), and digital speech characteristics—in 25 patients with ALS in an observational clinical trial setting to explore the impact of the devices on patients’ everyday life and to record tolerability related to the devices and study procedures over 48 weeks. Methods: In this exploratory, noncontrolled, nondrug study, patients attended a clinical site visit every 3 months to perform activity reference tasks while wearing a sensor, to conduct digital speech tests and for conventional ALS monitoring. In addition, patients wore the sensor in their daily life for approximately 3 days every month for the duration of the study. Results: The amount and quality of digital speech data captured at the clinical sites were as intended, and there were no significant issues. All the home monitoring sensor data available were propagated through the system and were received as expected. However, the amount and quality of physical activity home monitoring data were lower than anticipated. A total of 3 or more days (or partial days) of data were recorded for 65% of protocol time points, with no data collected for 24% of time points. At baseline, 24 of 25 patients provided data, reduced to 13 of 18 patients at Week 48. Lower-than-expected quality HRV data were obtained, likely because of poor contact between the sensor and the skin. In total, 6 of 25 patients had mild or moderate adverse events (AEs) in the skin and subcutaneous tissue disorders category because of skin irritation caused by the electrode patch. There were no reports of serious AEs or deaths. Most patients found the sensor comfortable, with no or minimal impact on daily activities. Conclusions: The platform can measure physical activity in patients with ALS in their home environment; patients used the equipment successfully, and it was generally well tolerated. The quantity of home monitoring physical activity data was lower than expected, although it was sufficient to allow investigation of novel physical activity end points. Good-quality in-clinic speech data were successfully captured for analysis. Future studies using objective patient monitoring approaches, combined with the most current technological advances, may be useful to elucidate novel digital biomarkers of disease progression.

23 June 2020 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Open access
MKMadeline Kelly
Madeline Kelly
ALArseniy Lavrov
Arseniy Lavrov
LGLuis Garcia-Gancedo
Luis Garcia-Gancedo
JPJim Parr
Jim Parr
RHRobert Hart
Robert Hart
KTKevin Talbot
Kevin Talbot
To explore novel, real-world biotelemetry disease progression markers in patients with amyotrophic lateral sclerosis (ALS) and to compare with clinical gold-standard measures. Methods: This was an exploratory, non-controlled, non-drug 2-phase study comprising a variable length Pilot Phase (n = 5) and a 48-week Core study Phase (n = 25; NCT02447952). Patients with mild or moderate ALS wore biotelemetry sensors for ∼3 days/month at home, measuring physical activity, heart rate variability (HRV), and speech over 48 weeks. These measures were assessed longitudinally in relation to ALS Functional Rating Scale-Revised (ALSFRS-R) score and forced vital capacity (FVC); assessed by telephone [monthly] and clinic visits [every 12 weeks]). Results: Pilot Phase data supported progression into the Core Phase, where a decline in physical activity from baseline followed ALS progression as measured by ALSFRS-R and FVC. Four endpoints showed moderate or strong between-patient correlations with ALSFRS-R total and gross motor domain scores (defined as a correlation coefficient of ≥0.5 or >0.7, respectively): average daytime active; percentage of daytime active; total daytime activity score; total 24-hour activity score. Moderate correlations were observed between speech endpoints and ALSFRS-R bulbar domain scores; HRV data quality was insufficient for reliable assessment. The sensor was generally well tolerated; 6/25 patients reported mostly mild or moderate intensity skin and subcutaneous tissue disorder adverse events. Conclusions: Biotelemetry measures of physical activity in this Pilot Study tracked ALS progression over time, highlighting their potential as endpoints for future clinical trials. A larger, formally powered study is required to further support activity endpoints as novel disease progression markers.

14 September 2017 in Sensors
Verified
Journal Article
Open access
PDF file
JAJavier Andreu-Perez
Javier Andreu-Perez
LGLuis Garcia-Gancedo
Luis Garcia-Gancedo
JMJonathan McKinnell
Jonathan McKinnell
ADAnniek Van der Drift
Anniek Van der Drift
APAdam Powell
Adam Powell
GYGuang-Zhong Yang
Guang-Zhong Yang
In addition to routine clinical examination, unobtrusive and physical monitoring of Rheumatoid Arthritis (RA) patients provides an important source of information to enable understanding the impact of the disease on quality of life. Besides an increase in sedentary behaviour, pain in RA can negatively impact simple physical activities such as getting out of bed and standing up from a chair. The objective of this work is to develop a method that can generate fine-grained actigraphies to capture the impact of the disease on the daily activities of patients. A processing methodology is presented to automatically tag activity accelerometer data from a cohort of moderate-to-severe RA patients. A study of procesing methods based on machine learning and deep learning is provided. Thirty subjects, 10 RA patients and 20 healthy control subjects, were recruited in the study. A single tri-axial accelerometer was attached to the position of the fifth lumbar vertebra (L5) of each subject with a tag prediction granularity of 3 s. The proposed method is capable of handling unbalanced datasets from tagged data while accounting for long-duration activities such as sitting and lying, as well as short transitions such as sit-to-stand or lying-to-sit. The methodology also includes a novel mechanism for automatically applying a threshold to predictions by their confidence levels, in addition to a logical filter to correct for infeasible sequences of activities. Performance tests showed that the method was able to achieve around 95% accuracy and 81% F-score. The produced actigraphies can be helpful to generate objective RA disease-specific markers of patient mobility in-between clinical site visits.

26 March 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VHValentin Hamy
Valentin Hamy
ACAndrew Creagh
Andrew Creagh
LGLuis Garcia-Gancedo
Luis Garcia-Gancedo
Measures of physical activity patterns that may characterize rheumatoid arthritis status were investigated, using actigraphy data from a large, prospective database study (UK Biobank). Population characterization identified 1080 individuals with rheumatoid arthritis who participated in accelerometer-measured physical activity data collection and met the eligibility criteria; these individuals were subsequently matched with 2160 non-rheumatoid arthritis controls. Raw actigraphy data were pre-processed to interpretable acceleration magnitude and general signal-based features were used to derive activity labels from a human activity recognition model. Qualitative assessment of average activity profiles indicated small differences between groups for activity in the first 5 hours of the day, engagement in moderate-to-vigorous activity, and evening sleep patterns. Of 145 metrics capturing different aspects of physical activity, 57 showed an ability to differentiate between participants with rheumatoid arthritis and non-rheumatoid arthritis controls, most notably activities related to moderate-to-vigorous activity, sleep and the ability to perform sustained activity, which remained different when adjusting for baseline imbalances. Objective measures derived from wrist-worn accelerometer data may be used to assess and quantify the impact of rheumatoid arthritis on daily activity and may reflect rheumatoid arthritis symptoms. This work represents an initial step towards the characterization of such impact. Importantly, this study offers a glimpse of the potential use of large-scale datasets to support the analysis of smaller clinical study datasets.